Your session is about to expire
← Back to Search
Multiple Dose: DT-216 for Friedreich Ataxia
Study Summary
This trial tests if a drug is safe & effective for treating Friedrich Ataxia in adults.
- Friedreich Ataxia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA provided its blessing to Multiple Dose: DT-216?
"Based on the limited amount of data collected thus far, our team at Power has assigned Multiple Dose: DT-216 a score of 1 for safety. This is largely due to it being in Phase 1 trials and having minimal evidence supporting efficacy or safety."
Is this research team still searching for participants?
"Affirmative. Clinicaltrials.gov records suggest that this experiment began recruiting on September 27th 2022, and is currently in progress. 38 individuals are needed to join the trial at one medical centre."
Are there certain participants that are more ideal for this research endeavor?
"To be eligible for this medical trial, Friedreich Ataxia patients need to between 18 and 55 years old. Furthermore, they must have a genetic confirmation of the condition with homozygous GAA repeat expansions on their record. Additionally, they should not exceed stage 5.5 on Functional Staging For Ataxia (FSA). Lastly, these potential participants will also require signing an informed consent form prior to enrollment into the study."
How many participants are receiving treatment in this clinical trial?
"Affirmative. Evidenced on clinicaltrials.gov, this medical experiment was first advertised in September 27th 2022 and is actively looking for participants; 38 individuals will be accepted at a single trial site."
Are octogenarians accepted into the clinical trial?
"Applicants for this medical trial must be over 18 years old and under 55 to fulfill the inclusion criteria."
Who else is applying?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger